Eosinophilic esophagitis: A potential complication of sublingual immunotherapy
Introduction. Eosinophilic esophagitis (EoE) represents chronic, a local immune-mediated disease with symptoms of esophageal dysfunction and histologically eosinophil-predominant inflammation and requires immediate endoscopy. Male gender is a strong risk factor. Case report. We presented a case of a...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN SR |
Publicado: |
Serbian Medical Society, Belgrade
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f82228eeccf4e7d9f059e3b8b021bf8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6f82228eeccf4e7d9f059e3b8b021bf8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6f82228eeccf4e7d9f059e3b8b021bf82021-12-05T21:29:00ZEosinophilic esophagitis: A potential complication of sublingual immunotherapy0354-71322217-399410.5937/opmed2102032Khttps://doaj.org/article/6f82228eeccf4e7d9f059e3b8b021bf82021-01-01T00:00:00Zhttps://scindeks-clanci.ceon.rs/data/pdf/0354-7132/2021/0354-71322101032K.pdfhttps://doaj.org/toc/0354-7132https://doaj.org/toc/2217-3994Introduction. Eosinophilic esophagitis (EoE) represents chronic, a local immune-mediated disease with symptoms of esophageal dysfunction and histologically eosinophil-predominant inflammation and requires immediate endoscopy. Male gender is a strong risk factor. Case report. We presented a case of a 25-year-old young man with a history of allergic rhino-conjunctivitis, asthma, and intermittent severe feeding disturbance. The patient had begun sublingual immunotherapy therapy, containing specific soluble allergens for ambrosia. Six weeks after starting the ambrosia sublingual immunotherapy he developed burning epigastric pain, dysphagia, and odynophagia. Six days later, he was admitted to an emergency department due to choking on a solid of food. Esophageal histopathological findings were in favor of EoE. Sublingual immunotherapy was discontinued. He feels well now. Conclusion. The majority of cases of Eosinophilic esophagitis are diagnosed in spring or fall, 1-2 months following the peak of pollen season. Dysphagia, chest pain, food sticking, and bolus obstruction are the most common symptoms. Endoscopic findings are Schatzki ring, edema, exudates, furrows, and strictures. Six biopsies should be taken from areas with endoscopic mucosal abnormalities, and infiltration of eosinophils (more than 15 eosinophils/HRI) (HRI - high resolution imaging) is necessary for the diagnosis confirmation. Treatment options are proton pump inhibitors - oral dispersible tablets of budesonide or fluticasone propionate, an elimination diet. Sublingual immunotherapy should be discontinued. Family physicians should be aware of this complication in evaluating patients with dysphagia.Knežević Snežana B.Dugalić Branimir D.Serbian Medical Society, Belgradearticleeosinophilic esophagitisdysphagiafood bolus impactionsublingual immunotherapyMedicine (General)R5-920ENSROpšta Medicina, Vol 27, Iss 1-2, Pp 32-39 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN SR |
topic |
eosinophilic esophagitis dysphagia food bolus impaction sublingual immunotherapy Medicine (General) R5-920 |
spellingShingle |
eosinophilic esophagitis dysphagia food bolus impaction sublingual immunotherapy Medicine (General) R5-920 Knežević Snežana B. Dugalić Branimir D. Eosinophilic esophagitis: A potential complication of sublingual immunotherapy |
description |
Introduction. Eosinophilic esophagitis (EoE) represents chronic, a local immune-mediated disease with symptoms of esophageal dysfunction and histologically eosinophil-predominant inflammation and requires immediate endoscopy. Male gender is a strong risk factor. Case report. We presented a case of a 25-year-old young man with a history of allergic rhino-conjunctivitis, asthma, and intermittent severe feeding disturbance. The patient had begun sublingual immunotherapy therapy, containing specific soluble allergens for ambrosia. Six weeks after starting the ambrosia sublingual immunotherapy he developed burning epigastric pain, dysphagia, and odynophagia. Six days later, he was admitted to an emergency department due to choking on a solid of food. Esophageal histopathological findings were in favor of EoE. Sublingual immunotherapy was discontinued. He feels well now. Conclusion. The majority of cases of Eosinophilic esophagitis are diagnosed in spring or fall, 1-2 months following the peak of pollen season. Dysphagia, chest pain, food sticking, and bolus obstruction are the most common symptoms. Endoscopic findings are Schatzki ring, edema, exudates, furrows, and strictures. Six biopsies should be taken from areas with endoscopic mucosal abnormalities, and infiltration of eosinophils (more than 15 eosinophils/HRI) (HRI - high resolution imaging) is necessary for the diagnosis confirmation. Treatment options are proton pump inhibitors - oral dispersible tablets of budesonide or fluticasone propionate, an elimination diet. Sublingual immunotherapy should be discontinued. Family physicians should be aware of this complication in evaluating patients with dysphagia. |
format |
article |
author |
Knežević Snežana B. Dugalić Branimir D. |
author_facet |
Knežević Snežana B. Dugalić Branimir D. |
author_sort |
Knežević Snežana B. |
title |
Eosinophilic esophagitis: A potential complication of sublingual immunotherapy |
title_short |
Eosinophilic esophagitis: A potential complication of sublingual immunotherapy |
title_full |
Eosinophilic esophagitis: A potential complication of sublingual immunotherapy |
title_fullStr |
Eosinophilic esophagitis: A potential complication of sublingual immunotherapy |
title_full_unstemmed |
Eosinophilic esophagitis: A potential complication of sublingual immunotherapy |
title_sort |
eosinophilic esophagitis: a potential complication of sublingual immunotherapy |
publisher |
Serbian Medical Society, Belgrade |
publishDate |
2021 |
url |
https://doaj.org/article/6f82228eeccf4e7d9f059e3b8b021bf8 |
work_keys_str_mv |
AT knezevicsnezanab eosinophilicesophagitisapotentialcomplicationofsublingualimmunotherapy AT dugalicbranimird eosinophilicesophagitisapotentialcomplicationofsublingualimmunotherapy |
_version_ |
1718370948477878272 |